Lighthouse Investment Partners LLC lifted its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 337.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 173,691 shares of the company's stock after purchasing an additional 134,010 shares during the period. Lighthouse Investment Partners LLC owned about 0.07% of Ryan Specialty worth $11,144,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Bar Harbor Wealth Management lifted its position in shares of Ryan Specialty by 5.9% during the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock worth $10,835,000 after purchasing an additional 9,482 shares in the last quarter. Barclays PLC increased its stake in shares of Ryan Specialty by 1.1% in the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after buying an additional 17,267 shares during the last quarter. Embree Financial Group increased its stake in shares of Ryan Specialty by 64.1% in the fourth quarter. Embree Financial Group now owns 83,212 shares of the company's stock worth $5,339,000 after buying an additional 32,500 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company's stock worth $56,545,000 after buying an additional 509,548 shares during the last quarter. Finally, KBC Group NV increased its stake in shares of Ryan Specialty by 1,803.6% in the fourth quarter. KBC Group NV now owns 46,181 shares of the company's stock worth $2,963,000 after buying an additional 43,755 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 11.10% of the company's stock.
Wall Street Analysts Forecast Growth
RYAN has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Royal Bank of Canada dropped their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. UBS Group lifted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Barclays dropped their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Finally, Keefe, Bruyette & Woods dropped their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty presently has an average rating of "Moderate Buy" and an average target price of $75.67.
Read Our Latest Stock Report on Ryan Specialty
Ryan Specialty Stock Down 0.1%
RYAN stock opened at $70.08 on Monday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1-year low of $52.34 and a 1-year high of $77.16. The firm has a fifty day moving average price of $70.16 and a two-hundred day moving average price of $68.73. The firm has a market cap of $18.35 billion, a price-to-earnings ratio of 101.57, a PEG ratio of 1.19 and a beta of 0.68.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. During the same quarter in the previous year, the firm earned $0.35 earnings per share. The firm's revenue for the quarter was up 25.0% compared to the same quarter last year. Research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is 141.18%.
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.